The clinical study evaluates the safety of a new catheter for Urinary Intermittent Catheterisation in self catheterized patients
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
22
Depending of the use of the self catheterized patient could be 4 to 6 Actreen Hydrolite Cath per day
Chartier-Kastler
Garches, France
Safety of Hydrolite Cath will be demonstrated by listing any adverse event(s) related to the use of Actreen® Hydrolite Cath and other occurrence
Time frame: All adverse event(s) occured during the 7 (±1) days, related to the use of Actreen Hydrolite Cath, will be registered.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.